Genflow Biosciences (OTCQB:GENFF) on Wednesday announced that its second European patent application (Application No. 23821586.7, Publication No. EP4630038), titled “SIRT6 Variant for NASH,” has been published in the European Patent Bulletin.
Publication of the patent application in the European Patent Bulletin follows entry into the European phase under the Patent Cooperation Treaty and represents a key milestone in Genflow’s expanding intellectual property portfolio.
The Institute of Chartered Accountants of Scotland (ICAS) has warned that the Chancellor’s cap on national insurance (NI) relief could...
Apr 17, 2026, 4:57 AM ETEuro / US Dollar (EUR:USD), GF, EWG, FXB, EWU, DAX, EWI, EWQ, FKU, FGM, GREK,...
Activist investor Bill Ackman has his sights set on Universal Music Group, and he’s launched a complex $64 billion proposal...
The Indian rupee rose to a one-week high on Friday after a Reuters report said the central bank took steps...
In India, buying gold is not just an investment—it is deeply rooted in tradition. People often purchase gold during festivals...
Shares of Wipro, India’s fourth-largest IT services company, fell as much as 4% to their day’s low of Rs 202...
The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.
